HRS Aluglaze IPO subscribed over 44.83x on day 3

The HRS Aluglaze subscription started on December 11, 2025, and will close on December 15, 2025, as per the schedule. The price band is set at ₹94 to ₹96 per share with a face value of ₹10 each.

Table of Contents

HRS Aluglaze IPO Subscription Status 

HRS Aluglaze IPO subscribed over 44.83x on its last day till 5.00 PM on December 15, 2025.    

  • HRS Aluglaze IPO subscription QIB investors’ portion is 19.48x, while NII subscribed 82.13x, and RII investors subscribed 49.54x. 
  • The company has received bids for 17,86,64,400 shares against 39,85,200 on offer for the last-day subscription. 
  • HRS Aluglaze IPO subscribed over 44.83x on its day 3. 
  • HRS Aluglaze IPO subscribed over 1.89X on its day 2. 
  • HRS Aluglaze IPO subscribed over  0.60x on its day 1. 

About HRS Aluglaze Company 

HRS Aluglaze Ltd, founded in 2012, is one of the leading companies involved in the designing, manufacturing, and installation of aluminium products such as windows, doors, curtain walls, cladding, and glazing systems. The firm is engaged in offering durable, stylish, and innovative aluminum windows and doors with quality and modern designs to transform your spaces into attractive ones. 

In addition to helping with material supply and procurement, the company provides builders, contractors, architects, and institutions with both standard and customized solutions. Moreover, its manufacturing facility is located at Village Rajoda, Taluka Bavla, Ahmedabad, Gujarat, spanning 11,176 square meters. Its manufacturing facility also consists of CNC precision machines and powder coating equipment. HRS Aluglaze has been working on 28 projects as of September 30, 2025.

HRS Aluglaze IPO GMP: 

HRS Aluglaze IPO GMP was ₹14 as of Monday, 15 December 2025. That indicates the IPO is trading at ₹110 with a ₹14 premium in the grey market against the issue price of ₹96. 

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *